Perineural dexamethasone as an adjuvant to bilateral erector spinae plane block for post-sternotomy pain after coronary artery bypass grafting: a randomized pilot trial with extended follow-up
Chronic poststernotomy pain (CPSP) affects 20–40% of patients within the first postoperative year after cardiac surgery. The effect of prolonged regional analgesia with perineural dexamethasone on long-term pain outcomes remains unclear. We conducted a pilot randomized trial to evaluate the long-term effects of dexamethasone added to bilateral erector spinae plane (ESP) blocks in patients undergoing coronary artery bypass grafting (CABG). In this single-center, randomized, double-blind pilot trial (NCT04313959), adults undergoing elective CABG via median sternotomy received a bilateral ultrasound-guided ESP block with ropivacaine alone or ropivacaine plus perineural dexamethasone (4 mg/side). Standardized multimodal analgesia was administered to both groups. Pain intensity and interference were assessed using the Brief Pain Inventory (BPI) at 30, 60, and 90 days and 3 y. The Short-Form McGill Pain Questionnaire (SF-MPQ) was administered 3 years after the initial assessment. The analyses were exploratory and based on the intention-to-treat principles. Forty-four patients were randomized, and 37 (84%) completed the 3-year follow-up. Pain scores decreased significantly over time in both groups (time effect, p < 0.001), with no significant group or group×time interaction observed. At 3 years, the mean BPI “average pain” was 0.35 ± 0.70 (ESP-LA) versus 0.30 ± 0.80 (ESP-LA + Dex). No participant reported sternotomy site pain at 3 y. The absolute risk difference for CPSP was 0% (95% CI, − 16.1% to 18.4%). No block-related complications were noted. In this pilot randomized trial with a 3 year follow-up, adding perineural dexamethasone to the bilateral ESP block showed no significant between-group difference in long-term pain outcomes that could be detected within the limits of this pilot cohort. Both groups showed very low pain scores at 3 years. These exploratory findings require confirmation in adequately powered trials, including those with appropriate comparator arms. How this study might affect research, practice, or policy perineural dexamethasone may prolong acute analgesia but should not be expected to prevent CPSP alone; future trials should prioritize multimodal, longer-duration strategies to mitigate chronic pain after a sternotomy.Summary of Key Findings What this study adds in a randomized clinical trial with a 3-year follow-up, adding perineural dexamethasone to the bilateral ESP block showed no significant difference in the incidence or severity of CPSP compared with local anesthetic alone within the limits of this pilot cohort; pain scores were very low in both groups, with no sternal pain at 3 years. What is already known on this topic Chronic post-sternotomy pain (CPSP) is reported in 20–40% of patients after cardiac surgery; erector spinae plane (ESP) blocks improve acute pain, but the effect of perineural dexamethasone on long-term pain prevention is uncertain.
Authors
- Filomena Regina Barbosa Gomes Galas (ORCID: https://orcid.org/0000-0003-0803-403X)
- Luis Alberto Rodriguez Linares (ORCID: https://orcid.org/0000-0003-1146-1841)
Institutions
- Universidade de São Paulo (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Instituto do Coração - HCFMUSP (BR)
Publication Details
- Journal
- Journal of Cardiothoracic Surgery
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1186/s13019-026-04587-8
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00